Advertisement

Related Videos

Robin Feldman, JD: Are Dubious Patents a Large or Small Issue?

Daniel Goldstein, MD: Interventional Pharmacoeconomics - Why and How

Opening Session Panel Discussion

Peter Clark, MA, MD, FRCP: A Payer Perspective

Varsha Gandhi, PhD, on Ibrutinib

Advertisement

Advertisement




Feb
26
Today In Oncology
How the Outlook on Fertility Preservation for Patients With Cancer Is Improving
SABCS 2025: Top Picks From a Breast Cancer Specialist
‘Prostate Screening Saved My Life’—Is That Really True In Most Cases?
Advanced Nonsquamous NSCLC FDA Grants Accelerated Approval to Zongertinib
Long-Term Health Risks for Testicular Cancer Survivors Differ by Chemotherapy Regimen
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo